市場調查報告書
商品編碼
1274235
心臟閉合裝置全球市場研究報告——2023-2030 年行業分析、規模、份額、增長、趨勢和預測Global Heart Closure Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
全球對心臟閉合裝置市場的需求將從 2022 年的 61.2 億美元增長到 2030 年的近 230.4 億美元,在 2023-2030 年研究期間的複合年增長率為 18.02% 據估計,
心臟閉合裝置是一種用於閉合心臟孔洞的醫療器械,例如卵圓孔 (PFO) 或房間隔缺損 (ASD)。 心臟閉合裝置用於稱為經導管閉合的微創手術以閉合孔。 心臟閉合裝置有多種類型,包括貼片、塞子和封堵器。 用心臟閉合裝置閉合心臟孔通常是安全的。 與心臟直視手術相比,它的成功率高,恢復時間短,並發症風險更低。
先天性心髒病患病率的增加是心臟閉合裝置市場的主要驅動力。 隨著人口的增長和老齡化,患有先天性心髒病的人數預計會增加,從而推動對心臟閉合裝置的需求。 此外,越來越多地採用微創手術也推動了心臟閉合裝置市場的增長。 此外,新的和更先進的心臟閉合裝置的開發正在推動市場增長。 此外,人們越來越意識到心臟閉合裝置的優勢,例如降低並發症的風險和更快的恢復,預計將增加對這些裝置的需求。 然而,這些設備的高成本可能會限制市場增長。
研究報告涵蓋波特五力模型、市場吸引力分析、價值鏈分析等。 這些工具可幫助您清楚地了解您的行業結構並評估您在全球範圍內的競爭吸引力。 此外,這些工具還對全球心臟閉合裝置市場的每個細分市場進行了全面評估。 心臟閉合裝置行業的發展和趨勢為這項研究提供了一個整體方法。
本部分按國家和地區提供詳細的細分數據,以幫助您確定目標受眾以及您的產品和服務的未來商機。
本節涵蓋區域展望,重點介紹北美、歐洲、亞太地區、拉丁美洲、中東和非洲心臟閉合裝置市場當前和未來的需求。 此外,我們還關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的綜合概況和全球競爭格局的詳細視圖。 心臟閉合裝置市場的主要參與者是雅培實驗室、W. L. Gore &Associates Inc、波士頓科學公司、Occlutech、Heartstitch、SMT、Cardia, Inc.、Lifetech Scientific Corp、樂普醫療技術(北京)有限公司、AtriCure Inc This部分概述了競爭格局,包括各種戰略發展,例如主要併購、未來能力、合作夥伴關係、財務概覽、合作、新產品開發和新產品發布。
注意:公司簡介中的財務細節和近期發展基於可用信息,可能不包括私營公司。
The global demand for Heart Closure Devices Market is presumed to reach the market size of nearly USD 23.04 BN by 2030 from USD 6.12 BN in 2022 with a CAGR of 18.02% under the study period 2023 - 2030.
Heart closure devices are medical devices used to close a hole in the heart, such as a patent foramen ovale (PFO) or an atrial septal defect (ASD). Heart closure devices are used in a minimally invasive procedure called transcatheter closure to seal the hole. There are several types of heart closure devices, including patches, plugs, and occluders. The procedure to close a hole in the heart with a heart closure device is generally safe. It has a high success rate, shorter recovery time and a lower risk of complications than open heart surgery.
The increasing prevalence of congenital heart defects, which are present at birth, is a major driver of the heart closure device market. As the population grows and ages, the number of people with congenital heart defects is expected to increase, driving demand for heart closure devices. Moreover, the increasing adoption of minimally invasive procedures drives growth in the heart closure device market. Also, developing new, more advanced heart closure devices is driving growth in the market. Furthermore, with the growing awareness of the benefits of heart closure devices, such as their low risk of complications and quick recovery time, demand for these devices is expected to increase. However, the high cost of these devices may limit the market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of heart closure devices. The growth and trends of heart closure devices industry provide a holistic approach to this study.
This section of the heart closure devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Heart Closure Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the heart closure devices market include Abbott Laboratories, W. L. Gore & Associates Inc, Boston Scientific Corp., Occlutech, Heartstitch, SMT, Cardia, Inc., Lifetech Scientific Corp., Lepu Medical Technology (Beijing)Co. Ltd., AtriCure Inc.. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.